Lipid Disorders
From the Journals
Ezetimibe plus statin: Attractive bypass to high-dose monotherapy
Early initiation of this approach should be considered in patients with challenging lipid disorders who are at increased risk of atherosclerotic...
From the Journals
For patients with peripheral artery disease, pain can be gain
Walking, especially when their legs hurt, made a significant positive difference for people with peripheral artery disease.
From the Journals
Remnant cholesterol captures residual CV risk in patients with T2D
Baseline and follow-up remnant cholesterol levels predict cardiovascular events in patients with type 2 diabetes.
From the Journals
Metabolic syndrome raises dementia risk in under-60s
A large follow-up study found a link between dementia risk and the number of components of metabolic syndrome a person has a midlife.
Guidelines
New update focuses on NAFLD in lean people
Lean individuals older than 40 with type 2 diabetes should be screened for NAFLD, urge experts.
From the Journals
‘Alarming’ global rise in NAFLD
Nearly one-third of adults around the world has nonalcoholic fatty liver disease, with cases steadily increasing over the years, and with men more...
From the Journals
Hypertension heightens risk for severe COVID-19, even in the fully vaxxed
Vaccinated and boosted adults with high blood pressure were more than twice likely to be hospitalized for COVID-19 than were those without...
From the Journals
Rosuvastatin again linked with risks to kidneys
Practice should more often heed FDA-recommended rosuvastatin dosages for patients with severe chronic kidney disease and step up monitoring for...
News
FDA clears endoscopic devices for sleeve gastroplasty, bariatric revision
The Apollo Endosurgery devices are the first and only ones approved for endoscopic sleeve gastroplasty and endoscopic bariatric revision, the...
Opinion
‘I shall harm’
Nocebo, from the Latin “I shall harm,” is the dark counterpart to the placebo.
From the Journals
Statins linked to lower diabetes risk after acute pancreatitis
Similar benefits were seen with low, moderate, and high statin doses, as well as in cases of both mild and severe acute pancreatitis.